FDA Approves Updated Labeling for Antiepileptic Drugs
May 5th, 2009 | 
Author: FDA MedWatch Alert
FDA Approves Updated Labeling for Antiepileptic Drugs
May 5, 2009
Audience: Neuropsychiatric healthcare professionals, other healthcare professionals, patients.
Update: FDA notified healthcare professionals that it approved updated labeling for antiepileptic drugs used to treat epilepsy, psychiatric disorders, and other conditions (e.g., migraine and neuropathic pain syndromes). FDA also required development of a medication guide, to be issued to patients each time the product is dispensed.
Related posts:
- New Safety Information for Tarceva (erlotinib) FDA MedWatch Alert New Safety Information for Tarceva (erlotinib)...
Related posts brought to you by Yet Another Related Posts Plugin.
Posted in 
Tags: 